Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium

BACKGROUND: Erythropoietin possesses cellular protection properties. The aim of the present study was to test the hypothesis that in situ expression of recombinant human erythropoietin (rhEPO) would improve tissue repair in rat after myocardial infarction (MI). METHODS AND RESULTS: RhEPO-producing c...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ruvinov, Emil, Sharabani-Yosef, Orna, Nagler, Arnon, Einbinder, Tom, Feinberg, Micha S, Holbova, Radka, Douvdevani, Amos, Leor, Jonathan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2008
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2585557/
https://ncbi.nlm.nih.gov/pubmed/19014419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-1536-1-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak